Previous 10 | Next 10 |
Aridis Pharmaceuticals CEO to Participate in a Fireside Chat Presented by Maxim Group LLC and Hosted by M-Vest on June 7 PR Newswire LOS GATOS, Calif. , June 3, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company ...
Aridis Pharmaceuticals press release (NASDAQ:ARDS): Q1 GAAP EPS of -$0.44 beats by $0.07. Revenue of $1.18M misses by $0.82M. For further details see: Aridis Pharmaceuticals GAAP EPS of -$0.44 beats by $0.07, revenue of $1.18M misses by $0.82M
Aridis Pharmaceuticals Announces First Quarter 2022 Financial Results and Business Update PR Newswire Multiple clinical data readouts expected in second half of 2022 LOS GATOS, Calif. , May 16, 2022 /PRNewswire/ -- Aridis Pharmaceuticals, Inc....
Veru (NASDAQ:VERU) shares are up 18% in Monday morning trading after the company presented phase 2 results over the weekend on oral sabizabulin in patients with severe COVID-19 at high risk for acute respiratory distress syndrome. In the trial of ~40 patients hospitalized with COVID...
Aridis Pharmaceuticals press release (NASDAQ:ARDS): Q4 GAAP EPS of -$0.92 misses by $0.59. Revenue of $0.57M misses by $1.33M. For further details see: Aridis Pharmaceuticals GAAP EPS of -$0.92 misses by $0.59, revenue of $0.57M misses by $1.33M
Aridis Pharmaceuticals Announces 2021 Fourth Quarter and Year-End Financial Results and Business Update PR Newswire Awarded funding from the Gates Foundation to support development of inhaled formulation technology to deliver cost-effective monoclonal antibodies agai...
Gainers: Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen ISPC -10%. Poseida ...
Pharmaceuticals (NASDAQ:ARDS) said both of its fully human monoclonal antibodies (mAbs) in the AR-701 cocktail neutralized the SARS-CoV-2 Omicron variant in in-vitro. In addition, both mAbs conferred complete protection against Omicron infected animals when given either parenterally or by int...
Aridis' Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals Preventative treatment of animals infected with the Omicron variant with either mAb alone or the combination of the two mAbs comprising the AR-701 cocktail conferred co...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s price action in the markets has been choppy. Investors seem to be having difficulty pricing in this macro environment, plus geopolitical concerns that are heating up. However, there are certain pockets of the...
News, Short Squeeze, Breakout and More Instantly...
Aridis Pharmaceuticals Inc. Company Name:
ARDS Stock Symbol:
NASDAQ Market:
Aridis Pharmaceuticals Inc. Website:
Biomerieux (BMXMF) is expected to report for Q1 2024 Conn's Inc. (CONN) is expected to report $-0.65 for Q1 2025 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for quarter end 2024-04-30 Aridis Pharmaceuticals Inc. (ARDS) is expected to report for Q1 2024 China Jo-Jo ...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...
Commercial Metals Company (CMC) is expected to report $1 for Q3 2024 CREATD INC. (CRTD) is expected to report for Q1 2024 GMS Inc. (GMS) is expected to report $2.04 for Q4 2024 China Jo-Jo Drugstores Inc. (CJJD) is expected to report for Q4 2024 Eiger BioPharmaceuticals Inc. (EIGR...